More recently, Kadiyala et al. demonstrated significantly improved outcomes in IDH1-mt gliomas in mice, with the administration of a targeted inhibitor, either alone, or with radiation and TMZ [91,110]. Here, IDH1 is linked to central nervous system cancer.